Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in chinese premenopausal systemic lupus erythematosus patients

Journal of Clinical Rheumatology

Volumn 15, Issue 3, 2009, Pages 111-116

  Zhang, Chun Yan ^a   Lu, Liang Jing ^a   Li, Feng Hua ^a   Li, Hong Li ^a   Gu, Yue Ying ^a   Chen, Shun Le ^a   Bao, Chun De ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Carotid plaque; Risk factors; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; GLYCERYL TRINITRATE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; BRACHIAL ARTERY; CAROTID ARTERY; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR ENDOTHELIUM; ADOLESCENT; AGE; BODY MASS; CAROTID ARTERY DISEASE; CASE CONTROL STUDY; CHINA; HOSPITALIZATION; INTIMA; MIDDLE AGED; PATHOLOGY; TUNICA MEDIA; VASODILATATION;

ADOLESCENT; ADULT; AGE FACTORS; ATHEROSCLEROSIS; BODY MASS INDEX; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CHINA; FEMALE; HUMANS; HYPERTENSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREMENOPAUSE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TUNICA INTIMA; TUNICA MEDIA; VASODILATION; YOUNG ADULT;

EID: 67649687450     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31819d8489     Document Type: Article

References (33)

1. Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythema-tosus: comparison with the Framingham Study. Am J Epidemiol. 1997;145: 408-415.
2. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42:338-346.
3. Woo KS, Donnan SP. Epidemiology of coronary arterial disease in the Chinese. Int J Cardiol. 1989;24:83-93.
4. Donnan SP, Ho SC, Woo J, et al. Risk factors for acute myocardial infarction in a southern Chinese population. Ann Epidemiol. 1994;4:46-58.
5. Woo J, Ho SC, Wong SL, et al. Lipids, lipoproteins, and other coronary risk factors in Chinese male survivors of myocardial infarction. Int J Cardiol. 1993;39:195-202.
6. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2399-2406.
7. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42:51-60.
8. Doria A, Shoenfeld Y, Wu R, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis. 2003;62:1071-1077.
9. Jiménez S, García-Criado MA, Tàssies D, et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford). 2005;44:756-761.
10. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:14-22.
11. Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26:1235-1241.
12. Takase B, Uehata A, Akima T, et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol. 1998;82:1535-1539, A7-A8.
13. Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation. 2002;105:1567-1572.
14. Gokce N, Keaney JF, Hunter LM, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in-patients with peripheral vascular disease. J Am Coll Cardiol. 2003;41:1769 -1775.
15. Brevetti G, Silvestro A, Schiano V, et al. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003; 108:2093-2098.
16. Roman MJ, Naqvi TZ, Gardin JM, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr. 2006;19:943-954.
17. Bhatt SP, Handa R, Gulati GS, et al. Atherosclerosis in Asian Indians with systemic lupus erythematosus. Scand J Rheumatol. 2006;35:128-132.
18. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
19. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol. 2003;92:17K-22K.
20. Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study. Diabetes. 2002;51:1596-1600.
21. Toloza SM, Uribe AG, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. Arthritis Rheum. 2004;50:3947-3957.
22. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165-2168.
23. Pasceri V, Cheng JS, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 2001;103:2531-2534.
24. Bruce IN. 'Not only . . . but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology(Oxford). 2005;44:1492-502.
25. Tam LS, Gladman D, Hallett D, et al. Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. J Rheumatol. 2000;27: 2142-2145.
26. Andrade RM, Alarcon GS. Antimalarials in systemic lupus erythematosus: benefits beyond disease activity. Future Rheumatol. 2006;1:225-233.
27. Borba EF, Bonfa E. Long-term beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy. J Rheumatol. 2001;28:780-785.
28. Alarcon GS, McGwin G, Bertoli AM, et al. Effects of hydroxychlorquine on the survival of patients with SLE: data from LUMINA a multi-ethnic US cohort (LUMINA L). Ann Rheum Dis. 2007;66:1168-1172.
29. Ruiz-Irastorza G, Egurbide MV, Pijoan JI, et al. Effect of antimalarial on thrombosis and survival in patients with systemic lupus erythematosus. Lupus. 2006;15:577-583.
30. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196.
31. Lima DS, Sato EI, Lima VC, et al. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol. 2001;29:292-297.
32. Piper MJ, Heaton SJ, Gardner-Medwin JM, et al. A study of endothelial function in systemic lupus erythematosus (SLE). Rheumatology. 2001; 40(suppl 1):113.
33. EI-Magadmi M, Bodill H, Ahmad Y, et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation. 2004;110:399-404.